Previous close | 12.89 |
Open | 12.77 |
Bid | 12.47 x 400 |
Ask | 12.70 x 100 |
Day's range | 12.31 - 12.77 |
52-week range | 10.62 - 18.44 |
Volume | |
Avg. volume | 77,224 |
Market cap | 417.662M |
Beta (5Y monthly) | -0.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.20 |
Earnings date | 10 May 2024 - 14 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 21.00 |
Director Peter Kim of Entrada Therapeutics Inc (NASDAQ:TRDA) has recently increased his stake in the company.
The analysts covering Entrada Therapeutics, Inc. ( NASDAQ:TRDA ) delivered a dose of negativity to shareholders today...
Extended Cash Runway and Progress in Duchenne Muscular Dystrophy Treatments Mark 2023 Milestones